Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Klinische Wochenschrift
|
February 4, 1985
The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies
H J Staab, T Brümmendorf, A Hornung, et al.
Biochemical and Biophysical Research Communications
|
November 14, 1984
Cell fusion responsible for horizontal oncogenesis by human tumors in nude mice
J Kömpf, H J Staab, H Heilbronner, et al.
British Journal of Cancer
|
May 1, 1982
Prognostic value of preoperative serum CEA level compared to clinical staging: II. Stomach cancer
H J Staab, F A Anderer, T Brümmendorf, et al.
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1980
Carcinoembryonic antigen (CEA) measurements as an aid to management of patients with lung cancer treated by radiotherapy
L M Ahlemann, H J Staab, H L Koch, et al.
British Journal of Cancer
|
November 1, 1981
Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma
H J Staab, F A Anderer, T Brümmendorf, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
Enhancement of MHC-unrestricted cytotoxic activity of human CD56+ CD3- natural killer (NK) cells and CD3+ T cells by rhamnogalacturonan: target cell specificity and activity against NK-insensitive targets
H G Zhu, T M Zollner, A Klein-Franke, et al.
British Journal of Cancer
|
November 1, 1982
Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer
H J Staab, F A Anderer, A Hornung, et al.
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1980
Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer
H J Staab, L M Ahlemann, H L Koch, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 9, 1980
Is serum beta 2-microglobulin a tumor marker in gastrointestinal cancer?
H J Staab, F A Anderer, K Hiesche, et al.
Deutsche Medizinische Wochenschrift (1946)
|
December 20, 1985
[Carcinoembryonic antigen: diagnosis and tumor progression in gastrointestinal tumors]
T Brümmendorf, F A Anderer, H J Staab, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Klinische Wochenschrift
|
February 4, 1985
The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies
H J Staab, T Brümmendorf, A Hornung, et al.
Biochemical and Biophysical Research Communications
|
November 14, 1984
Cell fusion responsible for horizontal oncogenesis by human tumors in nude mice
J Kömpf, H J Staab, H Heilbronner, et al.
British Journal of Cancer
|
May 1, 1982
Prognostic value of preoperative serum CEA level compared to clinical staging: II. Stomach cancer
H J Staab, F A Anderer, T Brümmendorf, et al.
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1980
Carcinoembryonic antigen (CEA) measurements as an aid to management of patients with lung cancer treated by radiotherapy
L M Ahlemann, H J Staab, H L Koch, et al.
British Journal of Cancer
|
November 1, 1981
Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma
H J Staab, F A Anderer, T Brümmendorf, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
Enhancement of MHC-unrestricted cytotoxic activity of human CD56+ CD3- natural killer (NK) cells and CD3+ T cells by rhamnogalacturonan: target cell specificity and activity against NK-insensitive targets
H G Zhu, T M Zollner, A Klein-Franke, et al.
British Journal of Cancer
|
November 1, 1982
Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer
H J Staab, F A Anderer, A Hornung, et al.
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1980
Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer
H J Staab, L M Ahlemann, H L Koch, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 9, 1980
Is serum beta 2-microglobulin a tumor marker in gastrointestinal cancer?
H J Staab, F A Anderer, K Hiesche, et al.
Deutsche Medizinische Wochenschrift (1946)
|
December 20, 1985
[Carcinoembryonic antigen: diagnosis and tumor progression in gastrointestinal tumors]
T Brümmendorf, F A Anderer, H J Staab, et al.
Page
of 9